Vascular Skin Disease
- Laser Therapy: Potential and Challenges
- Infantile Hemangioma Management Improved via Telemedicine
- The Most Frequent Cutaneous Manifestation After COVID-19 Vaccination
- PDL With Timolol Maleate Solution Addresses Infantile Hemangiomas
- Risk for Misdiagnosis of Capillary Malformations in Patients With Skin of Color
- Pro-Yellow Laser Effective, Safe for Vascular Skin Lesions
- Prevalence of Vascular Risk Factors High for Hispanics/Latinos
- SLE Patients, Regardless of Comorbid CV Disease, Have Blunted Microvascular Reactivity
- Is “COVID-19 Toe” Underrepresented in People of Color?
- PDL Without General Anesthesia is Well Tolerated by Infants, Toddlers
- Propranolol for the Treatment of Infantile Hemangiomas: Practices Vary by Country and Clinician
- Guideline Offers Treatment Recommendations for Vascular Anomalies
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
